Celiac Disease: Pediatric and Adult Management (RECORDING)

Sunday, September 14, 2025, 12:00 PM - Sunday, September 13, 2026, 11:59 AM, On Demand

In this recorded discussion, leading celiac disease experts Dr. Hilary Jericho, pediatric gastroenterologist and Medical Director of the Celiac Disease Program at Lucile Packard Children’s Hospital, and Dr. Nielsen Fernandez-Becker, Director of the Celiac Disease Program at Stanford Health Care, explored the complexities of celiac disease across all ages. They discussed typical and atypical presentations, screening strategies, the non-biopsy diagnostic approach in children, and the importance of confirming diagnosis before starting a lifelong gluten-free diet. The conversation also addressed psychosocial challenges and highlighted emerging therapies and groundbreaking research.

Release Date: September 14, 2026

Expiration Date: September 13, 2026

Estimated Time To Complete:~37 minutes

Registration Fee: Free

Click the Begin tab to launch this course.

AMA PRA Category 1 Credits™ (0.50 hours), Non-Physician Participation Credit (0.50 hours)

1. Utilize strategies to correctly diagnose and manage celiac disease
2. Review the transition process from pediatric to adult healthcare for patients with celiac disease

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require accommodations, please contact the CME Office.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

References/Bibliography
1.Conger, K. (2024). Organoids mimicking celiac disease show new link between gluten, intestinal damage. Stanford Medicine News Center. https://med.stanford.edu/news/all-news/2024/07/organoids-celiac-disease-gluten-intestinal-damage.html 
2.Hoffenberg, E. J., Celiac Disease Foundation. (n.d.). Celiac Disease in Children. Celiac Disease Foundation. https://celiac.org/about-celiac-disease/celiac-disease-in-children/ 
3.Mayo Clinic. (2023). Celiac Disease, Diagnosis & treatment. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/celiac-disease/diagnosis-treatment/drc-20352225 
4.Mayo Clinic. (2023). Celiac Disease, Symptoms & causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/celiac-disease/symptoms-causes/syc-20352220 
5.Popp, A., & Mäki, M. (2019). Changing Pattern of Childhood Celiac Disease Epidemiology: Contributing Factors. Frontiers in pediatrics, 7, 357. https://doi.org/10.3389/fped.2019.00357 
For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity.